SB 198 Summary

• University of Alaska Anchorage Center for Alcohol and Addiction Studies shall conduct a study evaluating the effectiveness of long-acting reversible contraception for women with substance abuse disorders at high risk for unintended pregnancies.

• Study must establish an advisory council, evaluate best practices for treating women and children at risk of neonatal abstinence syndrome or fetal alcohol spectrum disorders, and facilitate a network of hospitals and service providers to share best practices.

• University shall provide long-acting reversible contraception to study participants and evaluate its costs and effectiveness in reducing neonatal abstinence syndrome and fetal alcohol spectrum disorders.

• First interim report due by June 30, 2019, second interim report by June 30, 2020, and final report by June 30, 2021, with each submitted to the legislature.

• The study authorization repeals on June 30, 2021.